BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35208639)

  • 1. Muscle Quality of Knee Extensors Based on Several Types of Force in Multiple Sclerosis Patients with Varying Degrees of Disability.
    Portilla-Cueto K; Medina-Pérez C; Romero-Pérez EM; Núñez-Othón G; Horta-Gim MA; de Paz JA
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208639
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum amino acid profiling in differentiating clinical outcomes of multiple sclerosis.
    Rzepiński Ł; Kośliński P; Kowalewski M; Koba M; Maciejek Z
    Neurol Neurochir Pol; 2023; 57(5):414-422. PubMed ID: 37526173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of regression-based normative isometric strength values for major lower limb muscle groups in persons with multiple sclerosis.
    DelMastro HM; Simaitis LB; Gromisch ES; Gomes K; Ruiz JA
    Mult Scler Relat Disord; 2023 Jul; 75():104772. PubMed ID: 37247487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and relation of two arm function tests, Box and Blocks test and Nine Hole Peg test, across disease severity levels and types of multiple sclerosis.
    Bertoni R; Cattaneo D; Grosso C; Baglio F; Jonsdottir J
    Mult Scler Relat Disord; 2022 Mar; 59():103683. PubMed ID: 35168094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis.
    Gernert JA; Böhm L; Starck M; Buchka S; Kümpfel T; Kleiter I; Havla J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
    Knapp R; Hardtstock F; Krieger J; Wilke T; Maywald U; Chognot C; Muros-Le Rouzic E; Craveiro L
    Mult Scler Relat Disord; 2022 Dec; 68():104245. PubMed ID: 36306609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle architecture and its relationship with lower extremity muscle strength in multiple sclerosis.
    Kirmaci ZİK; Firat T; Özkur HA; Neyal AM; Neyal A; Ergun N
    Acta Neurol Belg; 2022 Dec; 122(6):1521-1528. PubMed ID: 34417688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom-Level Disability Status Assessed with an Electronic Unsupervised Patient-Reported Expanded Disability Status Scale (ePR-EDSS) in Multiple Sclerosis Patients-The Example of Croatia.
    Jerković A; Pavelin S; Šoda J; Vujović I; Rogić Vidaković M
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isometric tests to evaluate upper and lower extremity functioning in people with multiple sclerosis: reliability and validity.
    Uygur M; Barone DA; Dankel SJ; DeStefano N
    Mult Scler Relat Disord; 2022 Jul; 63():103817. PubMed ID: 35490451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of disability status in persons with multiple sclerosis by lower limb neuromuscular function - Emphasis on rate of force development.
    Taul-Madsen L; Riemenschneider M; Jørgensen MK; Dalgas U; Hvid LG
    Mult Scler Relat Disord; 2022 Nov; 67():104082. PubMed ID: 35933754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate of force relaxation scaling factor is highly sensitive to detect upper and lower extremity motor deficiencies in mildly affected people with multiple sclerosis.
    Uygur M; Barone DA
    Mult Scler Relat Disord; 2023 Sep; 77():104897. PubMed ID: 37481819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium.
    Jakimovski D; Kavak KS; Coyle PK; Goodman AD; Gottesman M; Zivadinov R; Weinstock-Guttman B;
    J Neurol; 2024 Feb; 271(2):711-722. PubMed ID: 37995009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis.
    Broekmans T; Gijbels D; Eijnde BO; Alders G; Lamers I; Roelants M; Feys P
    Mult Scler; 2013 Jan; 19(1):112-9. PubMed ID: 22562952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between lower extremity isometric muscle strength and standing balance in patients with multiple sclerosis.
    Citaker S; Guclu-Gunduz A; Yazici G; Bayraktar D; Nazliel B; Irkec C
    NeuroRehabilitation; 2013; 33(2):293-8. PubMed ID: 23949051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference Values for Isometric, Dynamic, and Asymmetry Leg Extension Strength in Patients with Multiple Sclerosis.
    Portilla-Cueto K; Medina-Pérez C; Romero-Pérez EM; Hernández-Murúa JA; Oliveira CEP; de Souza-Teixeira F; González-Bernal JJ; Vila-Chã C; de Paz JA
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33147859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A national registry-based study of ethnic differences in people with multiple sclerosis in Iran.
    Ashtari F; Kavosh A; Baghbanian SM; Hosseini Nejad Mir N; Hosseini S; Razazian N; Majdinasab N; Farajzadegan Z; Shaygannejad V; Adibi I; Eskandarieh S; Sahraian MA
    Clin Neurol Neurosurg; 2024 Apr; 239():108216. PubMed ID: 38490075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
    Tilling K; Lawton M; Robertson N; Tremlett H; Zhu F; Harding K; Oger J; Ben-Shlomo Y
    Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Arachidonic Acid-Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis.
    Broos JY; Loonstra FC; de Ruiter LRJ; Gouda M; Fung WH; Schoonheim MM; Heijink M; Strijbis EMM; Teunissen C; Killestein J; de Vries HE; Giera M; Uitdehaag BMJ; Kooij G
    Neurology; 2023 Aug; 101(5):e533-e545. PubMed ID: 37290971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological efficacy and safety of mesenchymal stem cells (MSCs) therapy in people with multiple sclerosis (pwMS): An updated systematic review and meta-analysis.
    Vaheb S; Afshin S; Ghoshouni H; Ghaffary EM; Farzan M; Shaygannejad V; Thapa S; Zabeti A; Mirmosayyeb O
    Mult Scler Relat Disord; 2024 Jul; 87():105681. PubMed ID: 38838423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.